Washington, DC, October 19, 2009—The United States Bone and Joint Decade (USBJD) today announced an unparalleled program for its 2009 Global Network Conference to be held in Washington, D.C., Wednesday, October 21–Saturday, October 24. The conference will bring together the official Bone and Joint Decade National Action Network (NAN) representatives from 56 countries, members of the administration, government policymakers, health care providers, patients, and patient advocates for a two-day Patient Advocacy Meeting on October 21-22 and a two-day Global Network Conference on October 23-24.
The Global Network Conference is an education and strategic planning meeting, which will highlight the significant burden of disease posed by musculoskeletal conditions and why raising awareness and engaging in advocacy are important means of advancing prevention and treatment. On October 22, there will be a focus on raising awareness of musculoskeletal conditions on Capitol Hill for U.S. delegates, patients, and the leadership of USBJD participating organizations.
Program highlights include:
Featured program participants include Sens. Chuck Grassley (R-Iowa) and John Barrasso (R-Wyo.), Congressmen Charles Rangel (D-N.Y.), Dave Camp (R-Mich.), and Charlie Melancon (D-La.), and Colin Carrie, Parliamentary Secretary for Health of Canada.
The Bone and Joint Decade is an international collaborative movement sanctioned by the United Nations and World Health Organization. Its mission is to improve the quality of life for people with musculoskeletal conditions and to advance the understanding, prevention and treatment of these conditions. Musculoskeletal conditions include back pain, arthritis, osteoporosis, traumatic injuries, and childhood conditions. Currently, 63 national governments and more than 750 patient advocacy and health professional organizations endorse the efforts of the BJD. The Decade, which received a Presidential Proclamation, is represented in the United States by the USBJD, is a network of more than 100 healthcare professional, patient and public organizations, and has been endorsed by all 50 states, and 125 medical schools. To further advance the goals of the Decade, more than 60 countries have formed National Action Networks (NAN) like the USBJD. For more information, please visit www.usbjd.org.
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.